The following facts are based on an analysis of Nova Scotia Cancer Registry data for the period 2008 to 2012, the most recent period for which complete data exist.
- About 29,600 people were diagnosed with invasive cancer in the five-year period 2008-2012. Males account for 52% of all new cancers during this period (15,325 cases), while females account for 48% (14,275 cases).
- Prostate, lung and colorectal cancers are the most common cancer types to affect NS males and account for slightly more than half (54%) of all cancer cases recorded between 2008 and 2012.
- Breast, colorectal and lung cancers are the cancer types that most commonly affect NS women and account for just more than half (56%) of all cancers recorded between 2008 and 2012.
- Prostate remains the most commonly occurring type of cancer among males, affecting approximately 740 men annually in the province.
- Among females, breast cancer remains the most common type of cancer diagnosis among, affecting nearly 770 women each year.
The following tables and figures provide more information about the burden of cancer in Nova Scotia. For greater detail regarding cancer incidence, mortality, survival, prevalence and projections in Nova Scotia, please refer to the Understanding Cancer in Nova Scotia report.
Table 1. New cases of invasive cancer, grouped by cancer site, Nova Scotia, 2008-2012.
Table 2. Incidence counts and rates of invasive cancers, by gender and District Health Authority, common cancer sites, Nova Scotia 2012.
Table 3. Incidence rates of invasive cancers, by gender and county, common cancer sites, Nova Scotia 2008-2012.
Table 4. Incidence rates of invasive cancers, by gender and District Health Authority (DHA), common cancer sites, Nova Scotia 2008-2012.
Figure 1. Average annual age-specific incidence rate for common cancer sites in females (A), males (B) and for all cancers (C), Nova Scotia 2008-2012.
Figure 2. Comparative incidence figures (CIF) of cancer rates1, comparing DHA and provincial level estimates, All Cancers (A), Prostate and Breast (B), Lung (C) and Colorectal (D) cancers, by gender, 2008-2012.